PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.45%
Revenue growth of 5.45% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
2.54%
Gross profit growth 1.25-1.5x Healthcare median of 1.84%. Mohnish Pabrai would see if economies of scale justify the premium growth.
-215.47%
Negative EBIT growth while Healthcare median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-15.44%
Negative operating income growth while Healthcare median is 4.88%. Seth Klarman would check if structural or cyclical issues are at play.
-117.73%
Negative net income growth while Healthcare median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-120.58%
Negative EPS growth while Healthcare median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-123.71%
Negative diluted EPS growth while Healthcare median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
-1.20%
Share reduction while Healthcare median is 0.40%. Seth Klarman would see a relative advantage if others are diluting.
-1.20%
Diluted share reduction while Healthcare median is 0.31%. Seth Klarman would see an advantage if others are still diluting.
No Data
No Data available this quarter, please select a different quarter.
-15.34%
Negative OCF growth while Healthcare median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
3.14%
FCF growth of 3.14% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
No Data
No Data available this quarter, please select a different quarter.
-43.07%
Negative 5Y CAGR while Healthcare median is 0.00%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
-27.65%
Negative 3Y CAGR while Healthcare median is 0.00%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
-3018.29%
Negative 10Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
67.43%
OCF/share CAGR of 67.43% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
-26.57%
Negative 3Y OCF/share CAGR while Healthcare median is 9.02%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
-5286.33%
Negative 10Y net income/share CAGR vs. Healthcare median of 30.98%. Seth Klarman might see a fundamental problem if peers maintain growth.
-248.74%
Negative 5Y CAGR while Healthcare median is 16.68%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
-882.73%
Negative 3Y CAGR while Healthcare median is 21.37%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
10337.78%
Equity/share CAGR of 10337.78% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
-34.81%
Negative 5Y equity/share growth while Healthcare median is 0.00%. Seth Klarman suspects firm-specific weaknesses if peers grow equity mid-term.
-58.34%
Negative 3Y equity/share growth while Healthcare median is -32.77%. Seth Klarman sees a short-term weakness if peers still expand net worth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.36%
AR growth of 8.36% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
0.65%
Inventory growth of 0.65% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
-1.65%
Assets shrink while Healthcare median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
0.34%
Positive BV/share change while Healthcare median is negative. Peter Lynch finds a strong advantage vs. peers failing to expand equity.
-3.77%
Debt is shrinking while Healthcare median is rising. Seth Klarman might see an advantage if growth remains possible.
-42.86%
R&D dropping while Healthcare median is rising. Seth Klarman wonders if we risk ceding future innovation or if peers overspend.
-7.77%
SG&A decline while Healthcare grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.